葡甘露聚醣（蒟蒻／魔芋） Glucomannan / Konjac Glucomannan (KGM) × 減重
Glucomannan for weight loss sits in genuine regulatory-vs-clinical-evidence conflict.
Glucomannan for weight loss sits in genuine regulatory-vs-clinical-evidence conflict. EFSA authorised a formal Article 13(1) health claim at 3 g/day (1 g x 3 doses with water before meals in an energy-restricted diet) based on its 2010 NDA panel review — a strong supportive signal at EU food-law level. However, the two highest-quality independent meta-analyses subsequent to that authorisation (Onakpoya 2014, 9 RCTs n=531, MD -0.22 kg NS; Zalewski 2015 systematic review, no clinically meaningful effect) found no significant weight-loss benefit; pediatric RCTs are consistently negative; only the older Sood 2008 fibre meta-analysis (-0.79 kg) and one small 2005 RCT support efficacy. The effect, if real, is therefore very small (~0.2-0.8 kg) and inconsistent across MAs. No US clinical society (TOS, AACE, Endocrine Society) endorses glucomannan; Cleveland Clinic's named obesity-medicine physician explicitly advises avoiding it; Mayo and Harvard do not address it; NIH ODS labels the evidence inconsistent. FDA has issued NO approved health claim (in direct contrast to EFSA). Combined with documented mechanical safety risks (oesophageal obstruction with tablets, Australia ADRAC ban 1985, FDA Import Alert 33-15) and clinically relevant drug interactions (additive hypoglycaemia with antidiabetics, absorption interference with levothyroxine/warfarin), the honest independent grade is C — weak/preliminary evidence with a real but small effect size at best, supported by EU regulatory authorisation but not by the strongest meta-analytic evidence or any US clinical society.
評分透明度
所有分數由 7 層證據引擎計算，過程公開可查▸查看完整決策路徑（audit trail）
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.346
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 高階證據未達主導 (0 positive vs 1 negative)，由 raw_score 決定
- tier_strict_requirement_check — Tier 條件達標，未降階
- detect_disputes — 偵測到 1 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status
社群以蒟蒻食品（麵/凍）討論為主，鮮少以「葡甘露聚醣膠囊」單一成分討論；多數認為靠蒟蒻不會瘦、關鍵仍是控制總熱量，並擔心蒟蒻凍隱藏糖分。
分歧偏負面：多人反映蒟蒻飽足感維持差、吃了像沒吃，普遍認為單靠蒟蒻不會瘦、仍須控制總熱量；以食品討論為主，作為單一保健成分的有感回饋極少
- 脹氣
- 腹瀉
- 便秘
- 腹部不適/胃脹胃痛
- 錠劑配水不足可能食道阻塞
- 蒟蒻凍隱藏糖分反致變胖
- 限制熱量的健康飲食型態
- 規律身體活動
- 結構化行為減重計畫
查看 ClaimReview 結構化資料 (JSON-LD)
{
"@context": "https://schema.org",
"@type": "ClaimReview",
"url": "https://gpt-dict.com/claim/CLM-COND-weight-loss-INT-glucomannan-001/",
"datePublished": "2026-06-01",
"author": {
"@type": "Organization",
"name": "gpt-dict.com",
"url": "https://gpt-dict.com"
},
"claimReviewed": "葡甘露聚醣（蒟蒻／魔芋）能改善減重",
"inLanguage": "zh-TW",
"itemReviewed": {
"@type": "Claim",
"appearance": []
},
"reviewRating": {
"@type": "Rating",
"ratingValue": 1,
"bestRating": 5,
"worstRating": 1,
"alternateName": "🔴 D 反證據"
}
}